Chiang Hsiangyi 4
4 · Imago BioSciences, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Chiang Hsiangyi
Senior Vice President Finance
Transactions
- Exercise/Conversion
Common Stock
2023-01-04$4.20/sh+19,941$83,752→ 26,538 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-01-04−19,941→ 86,206 totalExercise: $4.20Exp: 2031-02-04→ Common Stock (19,941 underlying)
Footnotes (2)
- [F1]Reflects the adjusted total which includes the purchase of 1,597 shares under the Imago Employee Stock Purchase Plan on November 30, 2022.
- [F2]The option vests with respect to 25% of the shares subject thereto on February 5, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.